0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Hugh Y. Rienhoff, Jr.
Akoya Biosciences
2 followers
Code.org
11 followers
Nkarta
1 follower
Scribe Therapeutics
1 follower
Singularity University
8 followers
SpringWorks Therapeutics
5 followers
Halozyme Therapeutics
4 followers
Prime Medicine
3 followers
MedSchoolCoach
2 followers
Coffeyville Community College
2 followers
Vista Higher Learning
2 followers
Explore companies